M&A Boom Keeping Biotech Investors Hungry After Wave of IPOs

Now watching

Next video starts in : 7 Play

M&A Boom Keeping Biotech Investors Hungry After Wave of IPOs

M&A Boom Keeping Biotech Investors Hungry After Wave of IPOs
Replay video
Up next

Apple Launches Streaming Music Service; Stocks Recover From Monday's Selloff

Unlock your personal NFL Now stream by signing in to NFL.com

M&A Boom Keeping Biotech Investors Hungry After Wave of IPOs

by TheStreet 1:58 mins

M&A Boom Keeping Biotech Investors Hungry After Wave of IPOs

by TheStreet 1:58 mins

Biotech companies raised $4.7 billion globally from 68 IPOs during the first half of 2014, and investor appetite will remain strong the rest of the year, said Greg Sarian, Partner at HighTower in Philadelphia. Sarian said there are 41 companies that have publicly filed to complete IPOs in the coming months and there remains a high level of interest in specialty biotech given the ongoing stream of M&A announcements. Furthermore, Sarian said that Federal Reserve Chair Janet Yellen's comment about stretched valuations in biotech stocks can be countered by strong Q2 earnings performances.

TheStreet

Personal Finance

  1. 1:07

    How to start investing in your 401(k)

  2. 2:23

    You can't go wrong if you major in a STEM field and other myths about college

  3. 2:17

    How much would you spend on your wedding?

  4. 1:10

    Money Minute: When is the right time to lock in your mortgage rate?

  5. 2:03

    The trade school dilemma: 'Should I or shouldn't I?'

  6. 1:14

    Money Minute: Paying off student debt or saving for retirement— which comes first?

Market Movers